<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Titratable Medications Reference Table - Adventist Health</title>
<style>
        /* Adventist Health Brand Styles */
        body {
            font-family: Arial, Helvetica, sans-serif;
            margin: 0;
            padding: 20px;
            background-color: #EFEFF0;
            font-size: 13px;
            line-height: 1.6;
        }
        
        .header {
            background-color: #003764;
            color: white;
            padding: 20px;
            text-align: center;
            margin: -20px -20px 20px -20px;
            border-bottom: 4px solid #00A0DD;
        }
        
        h1 {
            color: white;
            margin: 0;
            font-size: 28px;
            font-weight: 600;
            letter-spacing: 0.5px;
        }
        
        .subtitle {
            color: #00A0DD;
            font-size: 14px;
            margin-top: 8px;
            font-weight: 400;
        }
        
        .table-container {
            overflow-x: auto;
            background: white;
            padding: 20px;
            border-radius: 4px;
            box-shadow: 0 2px 8px rgba(0, 55, 100, 0.1);
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: 30px;
            table-layout: auto;
        }
        
        th {
            background-color: #003764;
            color: white;
            padding: 16px 12px;
            text-align: left;
            font-weight: 600;
            font-size: 12px;
            border: 1px solid #00A0DD;
            position: sticky;
            top: 0;
            z-index: 10;
            letter-spacing: 0.3px;
        }
        
        td {
            padding: 14px 12px;
            border: 1px solid #D6EEF0;
            vertical-align: top;
            font-size: 12px;
            line-height: 1.6;
            color: #55565A;
        }
        
        tr:nth-child(even) {
            background-color: #E1F0FB;
        }
        
        tr:hover {
            background-color: #D6EEF0;
        }
        
        .medication-name {
            font-weight: bold;
            color: #003764;
            font-size: 13px;
            min-width: 140px;
        }
        
        .high-alert {
            background-color: #FDDDD7;
            border-left: 4px solid #F8485E;
        }
        
        .non-formulary {
            background-color: #FFE5C2;
        }
        
        .warning {
            color: #F8485E;
            font-weight: 600;
        }
        
        .concentration {
            white-space: pre-wrap;
            min-width: 110px;
        }
        
        .goal-param {
            white-space: normal;
            max-width: 180px;
            line-height: 1.8;
        }
        
        .goal-param br::before {
            content: "• ";
            color: #003764;
            font-weight: bold;
        }
        
        .dosing {
            white-space: pre-wrap;
            min-width: 120px;
        }
        
        .comments {
            max-width: 450px;
            font-size: 11px;
            line-height: 1.7;
            color: #55565A;
            text-align: left;
            white-space: pre-wrap;
        }
        
        /* Medication Category Colors */
        .neuromuscular-blocker {
            background-color: #FDDDD7;
        }
        
        .sedative {
            background-color: #E0DEF0;
        }
        
        .vasopressor {
            background-color: #F0F7E8;
        }
        
        .antihypertensive {
            background-color: #E1F0FB;
        }
        
        .analgesic {
            background-color: #FFFCDF;
        }
        
        .inotrope {
            background-color: #D6EEF0;
        }
        
        .footer {
            text-align: center;
            margin-top: 30px;
            padding: 20px;
            color: #55565A;
            font-size: 10px;
            border-top: 2px solid #00A0DD;
        }
        
        /* Print Styles for Landscape Letter Size */
        @media print {
            @page {
                size: letter landscape;
                margin: 0.5in;
            }
            
            body {
                background-color: white;
                padding: 0;
                font-size: 9px;
            }
            
            .header {
                margin: 0;
                padding: 10px;
                page-break-after: avoid;
            }
            
            h1 {
                font-size: 18px;
            }
            
            .subtitle {
                font-size: 11px;
            }
            
            .table-container {
                box-shadow: none;
                padding: 0;
            }
            
            table {
                page-break-inside: auto;
                font-size: 8px;
            }
            
            thead {
                display: table-header-group;
            }
            
            tfoot {
                display: table-footer-group;
            }
            
            tr {
                page-break-inside: avoid;
                page-break-after: auto;
            }
            
            th {
                padding: 8px 6px;
                font-size: 9px;
                position: static;
            }
            
            td {
                padding: 6px 5px;
                font-size: 8px;
                line-height: 1.4;
            }
            
            .medication-name {
                font-size: 9px;
                min-width: 100px;
            }
            
            .comments {
                max-width: 280px;
                font-size: 7px;
                line-height: 1.5;
            }
            
            .goal-param {
                max-width: 120px;
                font-size: 8px;
            }
            
            .footer {
                page-break-before: avoid;
                font-size: 8px;
            }
        }
        
        @media (max-width: 768px) {
            body {
                padding: 10px;
            }
            .header {
                margin: -10px -10px 10px -10px;
                padding: 15px;
            }
            h1 {
                font-size: 20px;
            }
            .subtitle {
                font-size: 12px;
            }
        }
    </style></head>
<body>
<div class="header">
<h1>Titratable Medications Reference Table</h1>
<div class="subtitle">Adventist Health Medication Safety Standards</div>
<div class="table-container">
<table>
<thead>
<tr>
<th>Medication</th>
<th>Standard Concentration</th>
<th>Standard Dilution</th>
<th>Goal Parameter</th>
<th>Loading/Bolus Dose</th>
<th>Initial Rate</th>
<th>Increment Change</th>
<th>Frequency</th>
<th>Maximum Dose</th>
<th>Dosing Range</th>
<th>Order Comments</th>
</tr>
</thead>
<tbody>
<tr class="neuromuscular-blocker high-alert">
<td class="medication-name">atracurium<br/><span class="warning">**HIGH ALERT**</span></td>
<td class="concentration">#1: 0.5 mg/mL<br/>#2: 0.2 mg/mL</td>
<td class="dosing">50 mg/100 mL</td>
<td class="goal-param">
        • TOF 2 / 4  
        <br> Ventilator synchrony
        <br> Other</td>
<td>0.5 mg/kg, other</td>
<td>2 mcg/kg/min</td>
<td>1 mcg/kg/min</td>
<td>15 min</td>
<td>15 mcg/kg/min</td>
<td>1 - 15 mcg/kg/min</td>
<td class="comments">**HIGH ALERT DRUG**<br/>Warning, paralyzing agent causes respiratory depression.<br/> Patient must be ventilated and sedated prior to administration with RASS goal -4.  Do not titrate sedation off while on paralytic<br/>Obtain baseline train-of-four prior to beginning infusion.<br/><br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="neuromuscular-blocker high-alert">
<td class="medication-name">cisatracurium<br/><span class="warning">**HIGH ALERT**</span></td>
<td class="concentration">2 mg/mL</td>
<td class="dosing">200 mg/100 mL</td>
<td class="goal-param">• TOF 2 / 4                               Ventilator synchrony                 Other</td>
<td>0.2 mg/kg, other</td>
<td>1 mcg/kg/min</td>
<td>1 mcg/kg/min</td>
<td>15 min</td>
<td>10 mcg/kg/min</td>
<td>1 - 10 mcg/kg/min</td>
<td class="comments">**HIGH ALERT DRUG**<br/>Warning, paralyzing agent causes respiratory depression.<br/> Patient must be ventilated and sedated prior to administration with RASS goal -4.  Do not titrate sedation off while on paralytic<br/>Obtain baseline train-of-four prior to beginning infusion.<br/><br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive non-formulary">
<td class="medication-name">clevidipine<br/><span style="color: #E24301;">(AH non-formulary)</span></td>
<td class="concentration">0.5 mg/mL</td>
<td class="dosing">50 mg/100 mL <br/>25 mg/50 mL</td>
<td class="goal-param">• SBP 130 - 150                            SBP 130 - 160                         SBP 140 - 180                                 SBP 150 - 180 DBP &lt; 105      SBP 150 - 185 DBP &lt;110                                                                               SBP 160 - 200                                  Other</td>
<td>none</td>
<td>1 mg/hr</td>
<td>2 mg/hr</td>
<td>2 min</td>
<td>21 mg/hr</td>
<td>1 - 21 mg/hr</td>
<td class="comments">Change vial and tubing every 12 hours.<br/><br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">dexmedeTOMIDine</td>
<td class="concentration">4 mcg/mL</td>
<td class="dosing">400 mcg/100 mL<br/>200 mcg/50mL</td>
<td class="goal-param">• RASS 0 to -2</td>
<td>none</td>
<td>0.5 mcg/kg/hr</td>
<td>0.1 mcg/kg/hr</td>
<td>10 min</td>
<td>1.4 mcg/kg/hr</td>
<td>0.1 - 1.4mcg/kg/hr</td>
<td class="comments">Not appropriate alone if patient on neuromuscular blocker (NMB).<br/> <br/>Goal parameter must be monitored and documented every 10 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>If HR less than 60, decrease rate by half &amp; notify provider.<br/> <br/>If HR is less than or equal to 50, pause the infusion &amp; notify provider.<br/><br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">dilTIAZem</td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">125 mg/125 mL<br/>100 mg/100 mL</td>
<td class="goal-param">• HR 60 - 110                                Other</td>
<td>10 mg, 20 mg, other</td>
<td>5 mg/hr</td>
<td>2.5 mg/hr</td>
<td>15 min</td>
<td>15 mg/hr</td>
<td>2.5 to 15 mg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Turn IV off 2 hours after oral meds given.<br/><br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">DOBUTamine</td>
<td class="concentration">#1: 2000 mcg/mL<br/>#2: 4000 mcg/mL</td>
<td class="dosing">1000 mg/250 mL<br/>500 mg/250 mL</td>
<td class="goal-param">• MAP 65 - 75                         ScVO2 &gt; 70%                               CI 2 - 4                                          Other</td>
<td>none</td>
<td>2.5 mcg/kg/min</td>
<td>2.5 mcg/kg/min</td>
<td>5 min</td>
<td>20 mcg/kg/min</td>
<td>0.5 - 20 mcg/kg/min</td>
<td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Hold if HR &gt; 140.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/> RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">DOPamine</td>
<td class="concentration">#1: 3200 mcg/mL<br/>#2: 1600 mcg/mL</td>
<td class="dosing">800 mg/250 mL<br/>400 mg/250 mL</td>
<td class="goal-param">• MAP  65 - 75                            Other</td>
<td>none</td>
<td>2 mcg/kg/min</td>
<td>2 mcg/kg/min</td>
<td>2 min</td>
<td>20 mcg/kg/min</td>
<td>2 - 20 mcg/kg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br/>Rates greater than 10 mcg/kg/min must be administered via a central line.<br/><br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Hold if HR &gt; 140.<br/><br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/> <br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">EPINEPHrine</td>
<td class="concentration">#1: 20 mcg/mL<br/>#2: 40 mcg/mL</td>
<td class="dosing">2 mg/100 mL.                 5 mg/250 mL<br/>10 mg/250 mL</td>
<td class="goal-param">• MAP  65 - 75                             Other</td>
<td>none</td>
<td>1 mcg/min</td>
<td>1 mcg/min</td>
<td>2 min</td>
<td>20 mcg/min</td>
<td>1 - 20 mcg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br/>Rates greater than 15 mcg/min must be administered via a central line.<br/><br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Hold if HR &gt; 140.<br/><br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive">
<td class="medication-name">esmolol</td>
<td class="concentration">#1: 10 mg/mL<br/>#2: 20 mg/mL</td>
<td class="dosing">2500 mg/250 mL<br/>2000 mg/100 mL</td>
<td class="goal-param">• SBP 100 - 140                             SBP 130 - 160                            SBP 140 - 180                               HR 60 - 110                               Other</td>
<td>500 mcg/kg, 1000 mcg/kg, other</td>
<td>50 mcg/kg/min</td>
<td>50 mcg/kg/min</td>
<td>5 min</td>
<td>300 mcg/kg/min</td>
<td>50 - 300 mcg/kg/min</td>
<td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/> Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="analgesic">
<td class="medication-name">fentaNYL</td>
<td class="concentration">#1: 10 mcg/mL<br/>#2: 50 mcg/mL</td>
<td class="dosing">2500 mcg/250 mL<br/>1000 mcg/100 mL<br/>5000 mcg/100 mL<br/>500 mcg/50 mL</td>
<td class="goal-param">• CPOT 0 to 2                            Other</td>
<td>25 mcg, 50 mcg, 100 mcg, other</td>
<td>50 mcg/hr</td>
<td>25 mcg/hr</td>
<td>60 min</td>
<td>200 mcg/hr</td>
<td>25 - 200 mcg/hr</td>
<td class="comments">Warning: Medication causes respiratory depression.<br/> <br/>For Breakthrough Pain (CPOT &gt;2): Bolus 50 mcg every 5 minutes up to 3 times within one hour.<br/> If goal is not achieved after 3 consecutive boluses, then increase infusion rate.  <br/>Goal parameter must be monitored and documented every 60 minutes until goal is met.<br/><br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="analgesic">
<td class="medication-name">HYDROmorphone</td>
<td class="concentration">#1: 0.2 mg/mL<br/>#2: 1 mg/mL</td>
<td class="dosing">20 mg/100 mL<br/>100 mg/100 mL</td>
<td class="goal-param">• CPOT 0 to 2                             Other</td>
<td>0.4 mg, other</td>
<td>0.4 mg/hr</td>
<td>0.2 mg/hr</td>
<td>15 min</td>
<td>2 mg/hr</td>
<td>0.2 - 2 mg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">isoproterenol</td>
<td class="concentration">4 mcg/mL</td>
<td class="dosing">1000 mcg/250 mL<br/>2000 mcg/500 mL</td>
<td class="goal-param">• MAP 65 - 75                                HR 60 - 100                                Other</td>
<td>none</td>
<td>2 mcg/min</td>
<td>1 mcg/min</td>
<td>5 min</td>
<td>20 mcg/min</td>
<td>1 - 20 mcg/min</td>
<td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/> RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">ketamine (Sub-dissociative) (pain)</td>
<td class="concentration">#1: 2 mg/mL<br/>#2: 10 mg/mL</td>
<td class="dosing">500 mg/250 mL<br/>1000 mg/100 mL</td>
<td class="goal-param">• CPOT 0 to 2                          RASS 0 to - 2                         RASS - 4 to - 5 if on NMB              Other</td>
<td>0.25 mg/kg, other</td>
<td>0.05 mg/kg/hr</td>
<td>0.05 mg/kg/hr</td>
<td>60 min</td>
<td>0.3 mg/kg/hr</td>
<td>0.05 - 0.3 mg/kg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 60 minutes until goal is met.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">ketamine (Dissociative)</td>
<td class="concentration">#1: 2 mg/mL<br/>#2: 10 mg/mL</td>
<td class="dosing">500 mg/250 mL<br/>1000 mg/100 mL</td>
<td class="goal-param">• RASS - 4 to - 5 if on NMB            Other</td>
<td>1.5 mg/kg, 3 mg/kg, other</td>
<td>1 mg/kg/hr</td>
<td>0.5 mg/kg/hr</td>
<td>60 min</td>
<td>4 mg/kg/hr</td>
<td>1 - 4 mg/kg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 60 minutes until goal is met.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">labetolol</td>
<td class="concentration">5 mg/mL</td>
<td class="dosing">200 mg/40 mL<br/>400 mg/80 mL</td>
<td class="goal-param">• SBP 100 - 140                             SBP 130 - 160                            SBP 140 - 180                              HR 60 - 110                               Other</td>
<td>10 mg, 20 mg, other</td>
<td>1 mg/min</td>
<td>1 mg/min</td>
<td>15 min</td>
<td>4 mg/min</td>
<td>1 - 4 mg/min</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">LORazepam</td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">100 mg/100 mL<br/>50 mg/50 mL</td>
<td class="goal-param">• RASS 0 to - 2                              Other</td>
<td>1 mg, 2 mg, other</td>
<td>2 mg/hr</td>
<td>1 mg/hr</td>
<td>60 min</td>
<td>10 mg/hr</td>
<td>1 - 10 mg/hr</td>
<td class="comments">Monitor for propylene glycol toxicity.For RASS &gt; 0: Bolus 1 mg every 10 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.                                            <br/>Goal parameter must be monitored and documented every 60 minutes until goal is met.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">midazolam</td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">100 mg/100 mL<br/>50 mg/50 mL</td>
<td class="goal-param">• RASS 0 to - 2                         RASS - 4 to - 5 if on NMB              Other</td>
<td>1 mg, 2 mg, other</td>
<td>2 mg/hr</td>
<td>1 mg/hr</td>
<td>60 min</td>
<td>10 mg/hr</td>
<td>1 - 10 mg/hr</td>
<td class="comments">For RASS &gt; 0: Bolus 2 mg every 5 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.                                                                                                           <br/>Goal parameter must be monitored and documented every 60 minutes until goal is met.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="inotrope">
<td class="medication-name">milrinone</td>
<td class="concentration">#1: 200 mcg/mL<br/>#2: 400 mcg/mL</td>
<td class="dosing">20 mg/100 mL<br/>40 mg/100 mL</td>
<td class="goal-param">• CI 2 - 4                                     Other</td>
<td>none</td>
<td>0.25 mcg/kg/min</td>
<td>0.125 mcg/kg/min</td>
<td>30 min</td>
<td>0.75 mcg/kg/min</td>
<td>0.125 - 0.75 mcg/kg/min</td>
<td class="comments">Loading dose not typically given due to risk of hypotension. May require vasopressor support.<br/>Goal parameter must be monitored and documented every 30 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="analgesic">
<td class="medication-name">morphine</td>
<td class="concentration">#1: 1 mg/mL<br/>#2: 5 mg/mL</td>
<td class="dosing">100 mg/100 mL<br/>500 mg/100 mL</td>
<td class="goal-param">• CPOT 0 to 2                             Other</td>
<td>2 mg, 4 mg, other</td>
<td>2 mg/hr</td>
<td>1 mg/hr</td>
<td>15 min</td>
<td>20 mg/hr</td>
<td>1 - 20 mg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive">
<td class="medication-name">niCARdipine (Rapid Titration)</td>
<td class="concentration">#1: 0.1 mg/mL<br/>#2: 0.2 mg/mL</td>
<td class="dosing">20 mg/200 mL<br/>25 mg/250 mL<br/>40 mg/200 mL<br/>50 mg/250 mL</td>
<td class="goal-param">• SBP 130 - 150                            SBP 130 - 160                         SBP 140 - 180                                 SBP 150 - 180 and DBP &lt; 105      SBP 150 - 185 and DBP &lt;110                                                                           SBP 160 - 200                                  Other</td>
<td>none</td>
<td>5 mg/hr</td>
<td>2.5 mg/hr</td>
<td>5 min</td>
<td>15 mg/hr</td>
<td>2.5 - 15 mg/hr</td>
<td class="comments">Central line preferred. It is recommended to change infusion site every 12 hours to minimize peripheral venous irritation.                                                                                                                 <br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/>                                                               Once goal parameter is met, decrease infusion rate to 3 mg/hr.<br/>                                                       Once goal parameter is met, RN may document goal every 30-60 minutes.<br/>                                                                                                                                                                                                     Hold infusion if SBP is less than 120.                                                                                                <br/>Turn IV off 1 hour after oral meds are given.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive">
<td class="medication-name">niCARdipine</td>
<td class="concentration">#1: 0.1 mg/mL<br/>#2: 0.2 mg/mL</td>
<td class="dosing">20 mg/200 mL<br/>25 mg/250 mL<br/>40 mg/200 mL<br/>50 mg/250 mL</td>
<td class="goal-param">• SBP 130 - 150                            SBP 130 - 160                         SBP 140 - 180                                 SBP 150 - 180 and DBP &lt; 105      SBP 150 - 185 and DBP &lt;110                                                                               SBP 160 - 200                                  Other</td>
<td>none</td>
<td>5 mg/hr</td>
<td>2.5 mg/hr</td>
<td>15 min</td>
<td>15 mg/hr</td>
<td>2.5 - 15 mg/hr</td>
<td class="comments">Central line preferred. It is recommended to change infusion site every 12 hours to minimize peripheral venous irritation.                                                                                                               <br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/>                                                                                                                                                                                                     Hold infusion if SBP is less than 120.                                                                                              <br/>Turn IV off 1 hour after oral meds are given.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">nitroglycerin</td>
<td class="concentration">200 mcg/mL</td>
<td class="dosing">50 mg/250 mL</td>
<td class="goal-param">• SBP 100 - 140                             SBP 130 - 160                            SBP 140 - 180                               Other</td>
<td>none</td>
<td>10 mcg/min</td>
<td>10 mcg/min</td>
<td>5 min</td>
<td>200 mcg/min</td>
<td>10 - 200 mcg/min</td>
<td class="comments">Non-PVC tubing/container required. Tolerance may begin in 12 to 24 hours.<br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">nitroprusside</td>
<td class="concentration">#1: 200 mcg/mL<br/>#2: 500 mcg/mL</td>
<td class="dosing">50 mg/250 mL<br/>50 mg/100 mL</td>
<td class="goal-param">• SBP 100 - 140                             SBP 130 - 160                            SBP 140 - 180                         Other</td>
<td>none</td>
<td>0.2 mcg/kg/min</td>
<td>0.2 mcg/kg/min</td>
<td>5 min</td>
<td>4 mcg/kg/min</td>
<td>0.2 - 4 mcg/kg/min</td>
<td class="comments">Protect from light.<br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">NORepinephrine</td>
<td class="concentration">#1a: 16 mcg/mL<br/>#1b: 32 mcg/mL<br/><br/>#2: 128 mcg/mL</td>
<td class="dosing">4 mg/250 mL                 8 mg/250 mL<br/>32 mg/250mL</td>
<td class="goal-param">• MAP 65 - 75                            Other</td>
<td>none</td>
<td>4 mcg/min</td>
<td>2 mcg/min</td>
<td>2 min</td>
<td>30 mcg/min</td>
<td>2 - 30 mcg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br/>Rates greater than 15 mcg/min must be administered via a central line.<br/><br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/>  Contact provider to consider adding vasopressin once dose ≥ 8 mcg/min.<br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">phenylephrine</td>
<td class="concentration">#1: 80 mcg/mL<br/>#2: 400 mcg/mL</td>
<td class="dosing">20 mg/250 mL<br/>100 mg/250 mL</td>
<td class="goal-param">• MAP 65 - 75                            Other</td>
<td>none</td>
<td>50 mcg/min</td>
<td>10 mcg/min</td>
<td>5 min</td>
<td>200 mcg/min</td>
<td>10 - 200 mcg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.<br/>Rates greater than 150 mcg/min must be administered via a central line.<br/><br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">propofol</td>
<td class="concentration">10 mg/mL</td>
<td class="dosing">1000 mg/100 mL<br/>500 mg/50 mL</td>
<td class="goal-param">• RASS 0 to - 2                         RASS - 4 to - 5 if on NMB              Other</td>
<td>10 mg, 20 mg, other</td>
<td>10 mcg/kg/min</td>
<td>5 mcg/kg/min</td>
<td>5 min</td>
<td>60 mcg/kg/min</td>
<td>5 - 60 mcg/kg/min</td>
<td class="comments">Change vial and tubing every 12 hours.<br/>Check triglycerides at baseline and weekly. Consider more frequent TG level for high dose propofol<br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="neuromuscular-blocker high-alert">
<td class="medication-name">ROCuronium<br/><span class="warning">**HIGH ALERT**</span></td>
<td class="concentration">#1: 1 mg/mL<br/>#2: 10 mg/ml</td>
<td class="dosing">100 mg/100 mL<br/>300 mg/30 mL</td>
<td class="goal-param">• TOF 2 / 4                                Ventilator synchrony               Other</td>
<td>1 mg/kg, other</td>
<td>5 mcg/kg/min</td>
<td>1 mcg/kg/min</td>
<td>15 min</td>
<td>16 mcg/kg/min</td>
<td>1 - 16 mcg/kg/min</td>
<td class="comments">**HIGH ALERT DRUG**<br/>Warning, paralyzing agent causes respiratory depression.<br/> Patient must be ventilated and sedated prior to administration with RASS goal -4.  Do not titrate sedation off while on paralytic<br/>Obtain baseline train-of-four prior to beginning infusion.<br/><br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider  if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="neuromuscular-blocker high-alert">
<td class="medication-name">VECuronium<br/><span class="warning">**HIGH ALERT**</span></td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">100 mg/100 mL</td>
<td class="goal-param">• TOF 2 / 4                                Ventilator synchrony               Other</td>
<td>0.1 mg/kg, other</td>
<td>1 mcg/kg/min</td>
<td>0.1 mcg/kg/min</td>
<td>15 min</td>
<td>1.7 mcg/kg/min</td>
<td>0.1 - 1.7 mcg/kg/min</td>
<td class="comments">**HIGH ALERT DRUG**<br/>Warning, paralyzing agent causes respiratory depression.<br/> Patient must be ventilated and sedated prior to administration with RASS goal -4.  Do not titrate sedation off while on paralytic<br/>Obtain baseline train-of-four prior to beginning infusion.<br/><br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.<br/>                                                          Once goal parameter is met, RN may document goal every 30-60 minutes.<br/> <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.<br/><br/>Discontinue order if rate remains at zero for 23 hours.<br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
</tbody>
</table>
</div>
<div class="footer">
<strong>Adventist Health</strong> | Medication Safety Standards<br/>
        For internal use only | Updated: November 2025
    </div>
</div></body>
</html>
